Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2019 5
2020 4
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC.
Hellyer JA, Padda SK, Diehn M, Wakelee HA. Hellyer JA, et al. J Thorac Oncol. 2021 Mar;16(3):395-403. doi: 10.1016/j.jtho.2020.11.015. Epub 2020 Dec 8. J Thorac Oncol. 2021. PMID: 33307193 Review.
Adjuvant Chemotherapy.
Hellyer JA, Wakelee HA. Hellyer JA, et al. Thorac Surg Clin. 2020 May;30(2):179-185. doi: 10.1016/j.thorsurg.2020.01.003. Epub 2020 Mar 2. Thorac Surg Clin. 2020. PMID: 32327176 Review.
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
Aredo JV, Mambetsariev I, Hellyer JA, Amini A, Neal JW, Padda SK, McCoach CE, Riess JW, Cabebe EC, Naidoo J, Abuali T, Salgia R, Loo BW Jr, Diehn M, Han SS, Wakelee HA. Aredo JV, et al. Among authors: hellyer ja. J Thorac Oncol. 2021 Jun;16(6):1030-1041. doi: 10.1016/j.jtho.2021.01.1628. Epub 2021 Feb 12. J Thorac Oncol. 2021. PMID: 33588109
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
Foggetti G, Li C, Cai H, Hellyer JA, Lin WY, Ayeni D, Hastings K, Choi J, Wurtz A, Andrejka L, Maghini DG, Rashleigh N, Levy S, Homer R, Gettinger SN, Diehn M, Wakelee HA, Petrov DA, Winslow MM, Politi K. Foggetti G, et al. Among authors: hellyer ja. Cancer Discov. 2021 Jul;11(7):1736-1753. doi: 10.1158/2159-8290.CD-20-1385. Epub 2021 Mar 11. Cancer Discov. 2021. PMID: 33707235
15 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page